Oral, genital and anal human papillomavirus infections among female sex workers in Ibadan, Nigeria.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
19
01
2022
accepted:
25
02
2022
entrez:
30
3
2022
pubmed:
31
3
2022
medline:
15
4
2022
Statut:
epublish
Résumé
There are limited data on the epidemiology of HPV in different anatomical sites of female sex workers (FSW). We investigated the prevalence and concordance of cervical, vulval, oral and anal HPV among FSW in Ibadan, Nigeria. FSWs aged 18-45 years were enrolled in a cross-sectional survey. After interview and clinical examination, samples were collected from mouth, cervix, vulva and anus. HPV genotyping was done with Anyplex II 28HPV assay. Multivariable analyses were performed to explore associated risk factors and concordance of HPV infections across sites. In total, 315 FSWs participated in the study with a mean age of 30-6.5 years. The prevalence of any HPV infection was 88% in the vulva, 84% in the cervix, 75% in the anus and 24% in the oral cavity. HPV 35 was the most prevalent and concordant high-risk type in the four sites. The risk factors for HPV infection by anatomic site varied. This large study showed a high prevalence and concordance of HPV infections of cervical, vulval, oral and anal HPV among FSWs in Nigeria. The potential to acquire and transmit HPV is high in this population, and we highlighted the urgency to protect young women through HPV vaccination.
Sections du résumé
BACKGROUND
There are limited data on the epidemiology of HPV in different anatomical sites of female sex workers (FSW). We investigated the prevalence and concordance of cervical, vulval, oral and anal HPV among FSW in Ibadan, Nigeria.
METHODS
FSWs aged 18-45 years were enrolled in a cross-sectional survey. After interview and clinical examination, samples were collected from mouth, cervix, vulva and anus. HPV genotyping was done with Anyplex II 28HPV assay. Multivariable analyses were performed to explore associated risk factors and concordance of HPV infections across sites.
RESULTS
In total, 315 FSWs participated in the study with a mean age of 30-6.5 years. The prevalence of any HPV infection was 88% in the vulva, 84% in the cervix, 75% in the anus and 24% in the oral cavity. HPV 35 was the most prevalent and concordant high-risk type in the four sites. The risk factors for HPV infection by anatomic site varied.
CONCLUSION
This large study showed a high prevalence and concordance of HPV infections of cervical, vulval, oral and anal HPV among FSWs in Nigeria. The potential to acquire and transmit HPV is high in this population, and we highlighted the urgency to protect young women through HPV vaccination.
Identifiants
pubmed: 35353833
doi: 10.1371/journal.pone.0265269
pii: PONE-D-22-01775
pmc: PMC8967011
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0265269Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Open AIDS J. 2013 Dec 30;7:58-66
pubmed: 24511334
Eur J Cancer Care (Engl). 2014 Jan;23(1):65-75
pubmed: 23957436
Reprod Health. 2019 May 6;16(1):48
pubmed: 31060573
Carcinogenesis. 2010 May;31(5):918-26
pubmed: 20123756
Infect Agent Cancer. 2017 Jan 6;12:2
pubmed: 28070215
Int J STD AIDS. 2013 Mar;24(3):221-5
pubmed: 23535357
Int J Epidemiol. 2002 Feb;31(1):202-9
pubmed: 11914322
Lancet Glob Health. 2020 Feb;8(2):e191-e203
pubmed: 31812369
J Oncol. 2019 Jun 2;2019:8062176
pubmed: 31275383
Am J Obstet Gynecol. 2017 Jul;217(1):62.e1-62.e6
pubmed: 28267442
Afr J Med Med Sci. 2015 Mar;44(1):61-9
pubmed: 26548117
J Clin Microbiol. 2004 Mar;42(3):1330-2
pubmed: 15004111
Int J Cancer. 2009 Sep 1;125(5):1161-7
pubmed: 19415744
Clin Microbiol Infect. 2019 Dec;25(12):1560.e1-1560.e7
pubmed: 31051265
Jpn J Infect Dis. 2011;64(1):34-9
pubmed: 21266753
J Infect Dis. 2010 May 1;201(9):1331-9
pubmed: 20307204
BMC Public Health. 2020 Sep 25;20(1):1455
pubmed: 32977797
J Int AIDS Soc. 2018 Jun;21(6):e25110
pubmed: 29873885
Infect Agent Cancer. 2008 Apr 23;3:7
pubmed: 18433504
Int Q Community Health Educ. 2021 Apr 4;:272684X211006616
pubmed: 33818212
Int J STD AIDS. 2011 May;22(5):278-80
pubmed: 21571976
BMC Public Health. 2015 Jul 23;15:695
pubmed: 26202513
Adv Exp Med Biol. 2017;1018:23-34
pubmed: 29052130
Carcinogenesis. 2010 Jan;31(1):37-49
pubmed: 19955394
BMC Public Health. 2016 Jun 07;16:477
pubmed: 27266509
J Med Virol. 2018 Nov;90(11):1765-1774
pubmed: 30016541
Lancet. 2015 Jan 17;385(9964):287-301
pubmed: 25059950
Lancet Infect Dis. 2012 Jul;12(7):538-49
pubmed: 22424777
Papillomavirus Res. 2019 Jun;7:97-101
pubmed: 30771492
Int J Cancer. 2014 Mar 15;134(6):1389-98
pubmed: 23929250
J Infect. 2018 Apr;76(4):393-405
pubmed: 29289562
Int J STD AIDS. 2011 Nov;22(11):655-8
pubmed: 22096051
Lancet. 2015 Jan 3;385(9962):55-71
pubmed: 25059947
Int J Cancer. 2019 Mar 15;144(6):1302-1312
pubmed: 30144025
AIDS Care. 2019 Sep;31(9):1168-1171
pubmed: 30616357
Enferm Infecc Microbiol Clin (Engl Ed). 2019 May;37(5):324-334
pubmed: 30853139
Sex Reprod Healthc. 2016 Dec;10:3-8
pubmed: 27938869
Infect Agent Cancer. 2021 Sep 8;16(1):59
pubmed: 34496909